We're sunsetting PodQuest on 2025-07-28. Thank you for your support!
Export Podcast Subscriptions
cover of episode AI in the Supply Chain: Cold Chain Technologies’ Ranjeet Banerjee

AI in the Supply Chain: Cold Chain Technologies’ Ranjeet Banerjee

2022/1/11
logo of podcast Me, Myself, and AI

Me, Myself, and AI
AI Deep Dive AI Chapters Transcript
People
R
Ranjeet Banerjee
S
Shervin Khodabandeh
Topics
Ranjeet Banerjee: 冷链技术的核心挑战在于确保药物、生物制品和疫苗在长途运输过程中保持正确的条件，从而保证其安全性和有效性。人工智能可以预测运输过程中出现延误等问题对产品的影响，并据此采取干预措施，例如发出警报或安排新的运输。AI 的一个应用是预测产品到达收货人手中时是否完好无损且可用。结合路线、环境条件和包装设计，AI 可以预测产品到达时间和状态，从而采取相应的干预措施。技术是解决问题的工具，而不是目的本身；冷链技术的最终目标是确保药物在运输过程中保持有效性和及时性。AI 可以通过算法判断运输过程中的温度波动是否会影响产品质量，并自动化相关流程以提高效率和安全性。在冷链物流中使用AI技术之前，存在药物失效而无人知晓的情况，这导致了大量的浪费。温度控制药物运输的浪费率很高，高达10%到15%，疫苗的浪费率甚至更高，达20%。解决问题的流程应以问题为导向，而非技术为导向，先确定问题，再寻找合适的技术解决方案。解决冷链问题可以采用多种技术，例如AI和区块链。许多成功应用AI的企业都遵循“以问题为导向”的策略，先明确业务目标，再选择合适的技术。AI 是一场新的技术革命，可以解决许多以前无法解决的难题。供应链管理的视角正在从成本中心转向价值创造中心，通过技术手段提升客户满意度和合规性。企业需要将技术可能性与实际应用案例相结合，并通过与技术合作伙伴合作，不断学习和适应新的技术发展。冷链技术团队需要具备领域专业知识、IT技术能力和技术整合能力，同时领导层也需要积极参与学习和决策。领导层需要积极参与学习和决策，将不同领域的专家整合到一个团队中，共同解决问题。冷链技术的未来发展方向是提供更全面的解决方案，提升患者安全性和满意度，并通过数据和技术优化产品设计和选择。公司正在从单一的产品导向转变为多维度的创新模式，关注客户满意度、合规性和患者安全等方面。团队对新技术的应用反应积极，并得到了客户和合作伙伴的大力支持。 Sam Ransbotham: 对冷链物流中AI应用的提问和引导，例如AI如何预测产品状态，以及如何干预以保证产品质量。 Shervin Khodabandeh: 对冷链物流中AI应用的提问和引导，例如AI如何预测产品状态，以及如何干预以保证产品质量。对企业应用AI的策略和人才培养的讨论。

Deep Dive

Chapters
Ranjeet Banerjee discusses how AI is used in Cold Chain Technologies to provide assurance in the transport of temperature-sensitive drugs, vaccines, and biologics, focusing on predicting and managing delays and temperature excursions.

Shownotes Transcript

When Ranjeet Banerjee talks about the work his organization, Cold Chain Technologies (CCT), does to transport vaccines and other biologics that must be temperature controlled, he stresses that the company doesn’t solely rely on technology. CCT approaches its work by first considering what problems it’s trying to solve, developing use cases, and then considering whether a technology solution might be the best way forward.

In this episode, we learn how a combination of Ranjeet’s background in chemical engineering, his experience working in the health care space, and a holistic approach to leadership and problem-solving enable him to lead CCT to constantly innovate in the supply chain space. Ranjeet also discusses the benefits of a customer-first mindset and shares insights applicable to leaders in industries beyond health care. Read the episode transcript here).

*Me, Myself, and AI is a collaborative podcast from MIT Sloan Management Review *and Boston Consulting Group and is hosted by Sam Ransbotham and Shervin Khodabandeh. Our engineer is David Lishansky, and the coordinating producers are Allison Ryder and Sophie Rüdinger.

Stay in touch with us by joining our LinkedIn group, AI for Leaders at mitsmr.com/AIforLeaders).

Read more about our show and follow along with the series at https://sloanreview.mit.edu/ai).

Guest bio:

Ranjeet Banerjee is the CEO of Cold Chain Technologies (CCT), a leading global provider of comprehensive thermal assurance solutions for temperature-sensitive drugs, vaccines, and biologics. Under his leadership, CCT is playing a key role in the COVID-19 pandemic response, with both the Moderna and Johnson & Johnson vaccines exclusively using CCT’s thermal assurance packaging solutions across the U.S. CCT is also supporting the in-transit cold chain needs for vaccine distribution across the globe. Previously, Banerjee spent 25 years at global medical technology company Becton Dickinson, most recently serving as corporate executive vice president as well as president of the U.S. and Canada regions, with responsibility for more than $6 billion in revenue. Banerjee is a member of the Advisory Board for the CEO Leadership Alliance of Orange County. He earned a bachelor’s degree in chemical engineering from the Indian Institute of Technology.

We encourage you to rate and review our show. Your comments may be used in Me, Myself, and AI materials.

We want to know how you feel about Me, Myself, and AI. Please take a short, two-question survey).